Robert T. Abraham

39.9k citations
216 papers · 29.2k · 12 hit papers · h-index 88

Impact in

    • Cancer, Hypoxia, and Metabolism
    • PI3K/AKT/mTOR signaling in cancer
    • DNA Repair Mechanisms
    • Protein Kinase Regulation and GTPase Signaling

Papers in

    • PI3K/AKT/mTOR signaling in cancer 48
    • Protein Kinase Regulation and GTPase Signaling 30
    • DNA Repair Mechanisms 21
    • Immune Cell Function and Interaction 32
    • T-cell and B-cell Immunology 29

Robert T. Abraham

216 papers receiving 28.7k citations

Robert T. Abraham's Hit Papers

The PI3K Pathway in Human Disease 2017 · 2.0k citations
2.0k0+10+21Years since publication50010001.5k

Peers

Robert T. Abraham
Comparison fields: 5 of 166
  • Cancer Research 4.1k
  • Molecular Biology 19.4k
  • Immunology 5.7k
  • Oncology 6.9k
  • Cell Biology 3.1k
Replace Dafna Bar‐Sagi with:
Dafna Bar‐Sagi United States
Suzanne Cory Australia
David J. McConkey United States
Paul B. Fisher United States
Dario C. Altieri United States
Benjamin G. Neel United States
John L. Cleveland United States
Julian Downward United Kingdom
Nissim Hay United States
Kevan M. Shokat United States
Robert T. Abraham relative to Dafna Bar‐Sagi United States Dafna Bar‐Sagi's profile →
Citations per field
00.5×1.5×
Dafna Bar‐Sagi · 1×
Citations per year

Countries citing papers authored by Robert T. Abraham

Since Specialization
Citations

This map shows the geographic impact of Robert T. Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Abraham more than expected).

Fields of papers citing papers by Robert T. Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Abraham. The network helps show where Robert T. Abraham may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert T. Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert T. Abraham Line = papers co-authored together Robert T. Abraham links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The PI3K Pathway in Human Disease
Hit paper breakdown →
20171973
2
Cell cycle checkpoint signaling through the ATM and ATR kinases
Hit paper breakdown →
20011620
3
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
Hit paper breakdown →
19991074
4
Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin
Hit paper breakdown →
2002983
5
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Hit paper breakdown →
1999914
6
A role for ATR in the DNA damage-induced phosphorylation of p53
Hit paper breakdown →
1999853
7
Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Hit paper breakdown →
1997808
8
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Hit paper breakdown →
1995716
9
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002.
Hit paper breakdown →
1996635
10
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Hit paper breakdown →
1994612
11
A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Hit paper breakdown →
2000609
12
IMMUNOPHARMACOLOGY OF RAPAMYCIN
Hit paper breakdown →
1996537
13
Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
1998473
14 2005463
15 2004447
16 2000407
17 2004361
18 2005338
19 2002332
20 2015304

About Robert T. Abraham

Robert T. Abraham is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Cell Biology, having authored 216 papers that have together received 29.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (48 papers), Immune Cell Function and Interaction (32 papers), Protein Kinase Regulation and GTPase Signaling (30 papers), T-cell and B-cell Immunology (29 papers), DNA Repair Mechanisms (21 papers), Cytokine Signaling Pathways and Interactions (18 papers), Cancer-related Molecular Pathways (17 papers) and Microtubule and mitosis dynamics (14 papers). The work is most often cited by research in Cancer Research (4.1k citations), Molecular Biology (19.4k citations), Immunology (5.7k citations), Oncology (6.9k citations) and Cell Biology (3.1k citations). Robert T. Abraham has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Gary G. Chiang, Larry M. Karnitz, Gregory J. Wiederrecht, Randal S. Tibbetts, Jann N. Sarkaria, Shubha Bagrodia, Benjamin D. Hopkins, Lewis C. Cantley, Honyin Chiu and Christine C. Hudson. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, Molecular and Cellular Biology, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact